Home / Publications / China Insight - Lifesciences

China Insight - Lifesciences

Medical Device Manufacturers Risk Facing New Unannounced Inspections

01/07/2012

On 18 June 2012, the State Food and Drug Administration (“SFDA”) issued new regulations entitled “Interim Working Procedure of Unannounced Inspections over Manufacturing Enterprises of Medical Devices” (“Procedure”). Being the first framework regulation governing unannounced inspections for medical device manufacturers, it will undoubtedly have an important impact on all companies producing medical devices.

Please access the Newsletter below to read more.

Source
China Insight - Lifesciences
Read more

Authors

Portrait ofNicolas Zhu
Nicolas Zhu
Partner
Shanghai